Neko Health
NativePrivateUpdated November 3, 2026Full-body AI/ML diagnostic scanning
- Website
- www.nekohealth.com
- CEO
- Hjalmar Nilsonne
- Founded
- 2018
- HQ
- Stockholm, Sweden
- Total Funding
- $1.0B
- Employees
- 1001-5000
Products & Offerings
Neko Health Scan
A one-hour, non-invasive, radiation-free scan of skin, heart, circulation, blood and body composition, followed by a same-visit doctor consultation.
Neko Health member app with Apple Health integration
A member app that shows scan results and history, and since 2026 pulls in Apple Health wearable data for clinicians to review.
Derma-2
An FDA 510(k)-cleared full-body skin imaging system that combines visible-light, depth and thermal cameras for adjunctive mole and skin assessment.
Echo-2
An FDA 510(k)-cleared cardiovascular device, cleared in September 2026, used inside the Neko scan for heart assessment.
Spectrum-2
An FDA 510(k)-cleared device that measures oxygen levels in surface tissue as part of the circulation assessment.
Executive Summary
What they do
- Runs clinics offering a one-hour, radiation-free body scan with same-visit doctor review
- Builds its own sensor hardware for skin, heart, circulation and blood measurements
- Uses AI/ML to turn millions of scan data points into results doctors review
Why it matters
- Backed by about $1B in funding, including a $700M Series C at a reported ~$7B valuation
- Priced at $499 in the US, well below MRI-based rivals like Prenuvo
- Several devices received FDA 510(k) clearance in 2026, and its first US clinic opened in New York
Best fit
- Benefits teams looking at premium preventive health checks as an employee perk
- Health systems or payers tracking how consumer preventive screening models perform
- Executive health programs in London, Manchester, Birmingham, Stockholm or New York
Watch-outs
- Primarily a consumer clinic business with no proven employer or enterprise program
- Doctors warn of false positives, overdiagnosis and unnecessary follow-up testing
- FDA clearances cover individual devices, not the full screening service
Latest News
Inc.com · 10 days ago
PositiveFlow Space · 14 days ago
NeutralVocal · 18 days ago
PositiveAthletech News · 18 days ago
PositiveMarketWatch · 27 days ago
NeutralUnlock Full Intelligence
Pro members get the complete briefing
- Complete analyst verdict
- Risk assessment
- All 6 Bluescore dimension scores
- Traction signals
- Bluescore history & momentum tracking
- Unlimited company access
Neko Health is among the best-funded and fastest-growing preventive scan companies, with strong consumer demand and its first US clinic opened in September 2026. It still sells mainly to consumers through its own clinics, has no documented employer or payer offering, and the clinical value of broad screening is still debated. Enterprise buyers should watch its US expansion and any corporate-benefits product before starting a formal evaluation.
Signal Provenance
Latest observation date and source for each signal category
| Signal Category | Last Updated | Source |
|---|---|---|
Funding Signals Last funding round, Funding stage | Oct 30, 2026 | Montclare research agents |
Hiring Velocity Headcount, Headcount growth | Nov 3, 2026 | Montclare research agents |
Technical Output Research papers, GitHub activity | Nov 1, 2026 | Montclare research agents |
News Sentiment News mentions, News sentiment | Nov 3, 2026 | Montclare research agents |
Partnership Signals Enterprise partnerships, Distribution partners | Nov 3, 2026 | Montclare research agents |
Revenue Indicators ARR estimate, Revenue growth | Nov 3, 2026 | Montclare research agents |
Leadership Signals CEO tenure, Founder-led | Nov 3, 2026 | Montclare research agents |
Competitive Position Category rank, Market share | Oct 17, 2026 | Montclare research agents |
Why this Bluescore?
6 dimensions, each scored 0–10 against all — companies. Each adds its weight × score to the Bluescore — see methodology